Logotype for Progyny Inc

Progyny (PGNY) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Progyny Inc

Q3 2024 earnings summary

14 Jan, 2026

Executive summary

  • Q3 2024 revenue increased 2% year-over-year to $286.6 million, driven by growth in clients and covered lives, but results missed guidance due to lower ART cycle consumption and atypical member patterns.

  • Net income for Q3 2024 was $10.4 million ($0.11 per diluted share), down from $15.9 million ($0.16) in Q3 2023, reflecting lower gross margin and higher tax provision.

  • Gross margin declined to 20.7% from 22.3% year-over-year, mainly due to higher personnel-related costs and lower cycles per utilizer.

  • Adjusted EBITDA for Q3 2024 was $46.5 million, a 7% decrease from Q3 2023, with a margin of 16.2%.

  • Over 80 new clients and 1.1 million new covered lives were added, with strong adoption of new maternity, postpartum, and menopause services for 2025.

Financial highlights

  • Q3 2024 revenue: $286.6 million (+2% YoY); nine-month revenue: $868.8 million (+6% YoY).

  • Q3 2024 gross profit: $59.2 million (down 5% YoY); gross margin: 20.7% (down 160 bps YoY).

  • Q3 2024 Adjusted EBITDA: $46.5 million (down from $50.0 million YoY); nine-month Adjusted EBITDA: $151.2 million (up from $143.8 million YoY).

  • Q3 2024 net income: $10.4 million (down from $15.9 million YoY); nine-month net income: $43.8 million (down from $48.6 million YoY).

  • Operating cash flow for Q3 was $44.5 million, and $127 million year-to-date, with 84% conversion of Adjusted EBITDA.

Outlook and guidance

  • Q4 2024 revenue expected between $266.2 million and $281.2 million; full-year revenue guidance is $1.135 billion to $1.150 billion.

  • Q4 Adjusted EBITDA projected at $37.8 million–$42.8 million; net income $6.1 million–$9.5 million.

  • Full-year Adjusted EBITDA expected at $189 million–$194 million; net income $49.9 million–$53.3 million.

  • Guidance assumes continued variability in ART cycles per utilizer and utilization rates, with the loss of a major client in 2025 expected to impact future revenue.

  • Over 530 clients and 6.7 million covered lives expected in 2025 after new client launches.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more